Literature DB >> 20537953

Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies.

Philippe Georgel1, Catherine Schuster, Mirjam B Zeisel, Françoise Stoll-Keller, Thomas Berg, Seiamak Bahram, Thomas F Baumert.   

Abstract

With a global burden of 170 million chronically infected patients and a major cause of liver cirrhosis and hepatocellular carcinoma, hepatitis C virus (HCV) is a major public health challenge. Recent discoveries of viral and cellular factors mediating virus-host interactions have allowed scientists to uncover the key molecular mechanisms of viral infection and escape from innate and adaptive immune responses. These include the discovery of tight junction proteins as entry factors and microRNA-122, cyclophilins and lipoproteins as host factors for virus translation, replication and production. Furthermore, global genetic analyses have identified IL-28B as a genetic factor associated with the outcome of HCV infection. These discoveries markedly advance the understanding of the molecular pathogenesis of HCV infection and uncover novel targets for urgently needed antiviral strategies. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20537953     DOI: 10.1016/j.molmed.2010.04.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  24 in total

Review 1.  Mixing the right hepatitis C inhibitor cocktail.

Authors:  Michael A Gelman; Jeffrey S Glenn
Journal:  Trends Mol Med       Date:  2010-11-23       Impact factor: 11.951

2.  Association of low-density lipoprotein receptor genotypes with hepatitis C viral load.

Authors:  A Caruz; K Neukam; A Rivero-Juárez; R Herrero; L M Real; A Camacho; P Barreiro; P Labarga; A Rivero; J A Pineda
Journal:  Genes Immun       Date:  2013-10-31       Impact factor: 2.676

3.  Interplay among cellular polarization, lipoprotein metabolism and hepatitis C virus entry.

Authors:  Ignacio Benedicto; Francisca Molina-Jiménez; Ricardo Moreno-Otero; Manuel López-Cabrera; Pedro L Majano
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

4.  A human proteome microarray identifies that the heterogeneous nuclear ribonucleoprotein K (hnRNP K) recognizes the 5' terminal sequence of the hepatitis C virus RNA.

Authors:  Baochang Fan; Kuan-Yi Lu; F X Reymond Sutandy; Yi-Wen Chen; Kouacou Konan; Heng Zhu; C Cheng Kao; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2013-10-10       Impact factor: 5.911

5.  Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection?

Authors:  Raquel Francine Liermann Garcia; Simone Moreira; Ana Lucia de Araújo Ramos; Leslie Ecker Ferreira; Angelo Alves de Mattos; Cristiane Valle Tovo; Lysandro Alsina Nader; Juliene Antonio Ramos; Edson Rondinelli; Arnaldo de Jesus Dominici; Christian Evangelista Garcia; Mauro de Souza Leite Pinho; Carlos Eduardo Brandão-Mello; Cristiane Alves Villela-Nogueira; Paulo Henrique Condeixa de França
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

6.  Genome-wide association study among four horse breeds identifies a common haplotype associated with in vitro CD3+ T cell susceptibility/resistance to equine arteritis virus infection.

Authors:  Yun Young Go; Ernest Bailey; Deborah G Cook; Stephen J Coleman; James N Macleod; Kuey-Chu Chen; Peter J Timoney; Udeni B R Balasuriya
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

Review 7.  The role of microRNAs in hepatitis C virus replication and related liver diseases.

Authors:  Chang Ho Lee; Ji Hyun Kim; Seong-Wook Lee
Journal:  J Microbiol       Date:  2014-05-29       Impact factor: 3.422

8.  Correlation between IL-28 polymorphism and spontaneous clearance in HCV patients: systematic review and meta-analysis.

Authors:  Hamid Heidarian Miri; Pooria Fazeli; Mohammad Ali-Hassanzadeh; Peyman Bemani; Dieter Kabelitz; Kurosh Kalantar
Journal:  Arch Virol       Date:  2021-07-03       Impact factor: 2.574

9.  Transduction with Lentiviral Vectors Altered the Expression Profile of Host MicroRNAs.

Authors:  He Huang; Chongyang Zhang; Bei Wang; Fei Wang; Bin Pei; Chaofei Cheng; Wei Yang; Zhendong Zhao
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

10.  Prediction of response to pegylated-interferon-α and ribavirin therapy in Chinese patients infected with different hepatitis C virus genotype.

Authors:  Xiaoyan Guo; Zhixin Zhao; Junqiang Xie; Qingxian Cai; Xiaohong Zhang; Liang Peng; Zhiliang Gao
Journal:  Virol J       Date:  2012-06-19       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.